Johannes Pordzik, Katharina Bahr-Hamm, Tilman Huppertz, Haralampos Gouveris, Christopher Seifen, Andrew Blaikie, Christoph Matthias, Sebastian Kuhn, Jonas Eckrich, Christoph R Buhr
{"title":"大语言模型对阻塞性睡眠呼吸暂停患者的支持——关于一线气道正压和二线舌下神经刺激治疗常见问题的回答：一项试点研究。","authors":"Johannes Pordzik, Katharina Bahr-Hamm, Tilman Huppertz, Haralampos Gouveris, Christopher Seifen, Andrew Blaikie, Christoph Matthias, Sebastian Kuhn, Jonas Eckrich, Christoph R Buhr","doi":"10.2147/NSS.S495654","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Obstructive sleep apnoea (OSA) is a common disease that benefits from early treatment and patient support in order to prevent secondary illnesses. This study assesses the capability of the large language model (LLM) ChatGPT-4o to offer patient support regarding first line positive airway pressure (PAP) and second line hypoglossal nerve stimulation (HGNS) therapy.</p><p><strong>Methods: </strong>Seventeen questions, each regarding PAP and HGNS therapy, were posed to ChatGPT-4o. Answers were rated by experienced experts in sleep medicine on a 6-point Likert scale in the categories of medical adequacy, conciseness, coherence, and comprehensibility. Completeness of medical information and potential hazard for patients were rated using a binary system.</p><p><strong>Results: </strong>Overall, ChatGPT-4o achieved reasonably high ratings in all categories. In medical adequacy, it performed significantly better on PAP questions (mean 4.9) compared to those on HGNS (mean 4.6) (p < 0.05). Scores for coherence, comprehensibility and conciseness showed similar results for both HGNS and PAP answers. Raters confirmed completeness of responses in 45 of 51 ratings (88.24%) for PAP answers and 28 of 51 ratings (54.9%) for HGNS answers. Potential hazards for patients were stated in 2 of 52 ratings (0.04%) for PAP answers and none for HGNS answers.</p><p><strong>Conclusion: </strong>ChatGPT-4o has potential as a valuable patient-oriented support tool in sleep medicine therapy that can enhance subsequent face-to-face consultations with a sleep specialist. However, some substantial flaws regarding second line HGNS therapy are most likely due to recent advances in HGNS therapy and the consequent limited information available in LLM training data.</p>","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"16 ","pages":"2269-2277"},"PeriodicalIF":3.0000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687119/pdf/","citationCount":"0","resultStr":"{\"title\":\"Patient Support in Obstructive Sleep Apnoea by a Large Language Model - ChatGPT 4o on Answering Frequently Asked Questions on First Line Positive Airway Pressure and Second Line Hypoglossal Nerve Stimulation Therapy: A Pilot Study.\",\"authors\":\"Johannes Pordzik, Katharina Bahr-Hamm, Tilman Huppertz, Haralampos Gouveris, Christopher Seifen, Andrew Blaikie, Christoph Matthias, Sebastian Kuhn, Jonas Eckrich, Christoph R Buhr\",\"doi\":\"10.2147/NSS.S495654\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Obstructive sleep apnoea (OSA) is a common disease that benefits from early treatment and patient support in order to prevent secondary illnesses. This study assesses the capability of the large language model (LLM) ChatGPT-4o to offer patient support regarding first line positive airway pressure (PAP) and second line hypoglossal nerve stimulation (HGNS) therapy.</p><p><strong>Methods: </strong>Seventeen questions, each regarding PAP and HGNS therapy, were posed to ChatGPT-4o. Answers were rated by experienced experts in sleep medicine on a 6-point Likert scale in the categories of medical adequacy, conciseness, coherence, and comprehensibility. Completeness of medical information and potential hazard for patients were rated using a binary system.</p><p><strong>Results: </strong>Overall, ChatGPT-4o achieved reasonably high ratings in all categories. In medical adequacy, it performed significantly better on PAP questions (mean 4.9) compared to those on HGNS (mean 4.6) (p < 0.05). Scores for coherence, comprehensibility and conciseness showed similar results for both HGNS and PAP answers. Raters confirmed completeness of responses in 45 of 51 ratings (88.24%) for PAP answers and 28 of 51 ratings (54.9%) for HGNS answers. Potential hazards for patients were stated in 2 of 52 ratings (0.04%) for PAP answers and none for HGNS answers.</p><p><strong>Conclusion: </strong>ChatGPT-4o has potential as a valuable patient-oriented support tool in sleep medicine therapy that can enhance subsequent face-to-face consultations with a sleep specialist. However, some substantial flaws regarding second line HGNS therapy are most likely due to recent advances in HGNS therapy and the consequent limited information available in LLM training data.</p>\",\"PeriodicalId\":18896,\"journal\":{\"name\":\"Nature and Science of Sleep\",\"volume\":\"16 \",\"pages\":\"2269-2277\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11687119/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature and Science of Sleep\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/NSS.S495654\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S495654","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Patient Support in Obstructive Sleep Apnoea by a Large Language Model - ChatGPT 4o on Answering Frequently Asked Questions on First Line Positive Airway Pressure and Second Line Hypoglossal Nerve Stimulation Therapy: A Pilot Study.
Purpose: Obstructive sleep apnoea (OSA) is a common disease that benefits from early treatment and patient support in order to prevent secondary illnesses. This study assesses the capability of the large language model (LLM) ChatGPT-4o to offer patient support regarding first line positive airway pressure (PAP) and second line hypoglossal nerve stimulation (HGNS) therapy.
Methods: Seventeen questions, each regarding PAP and HGNS therapy, were posed to ChatGPT-4o. Answers were rated by experienced experts in sleep medicine on a 6-point Likert scale in the categories of medical adequacy, conciseness, coherence, and comprehensibility. Completeness of medical information and potential hazard for patients were rated using a binary system.
Results: Overall, ChatGPT-4o achieved reasonably high ratings in all categories. In medical adequacy, it performed significantly better on PAP questions (mean 4.9) compared to those on HGNS (mean 4.6) (p < 0.05). Scores for coherence, comprehensibility and conciseness showed similar results for both HGNS and PAP answers. Raters confirmed completeness of responses in 45 of 51 ratings (88.24%) for PAP answers and 28 of 51 ratings (54.9%) for HGNS answers. Potential hazards for patients were stated in 2 of 52 ratings (0.04%) for PAP answers and none for HGNS answers.
Conclusion: ChatGPT-4o has potential as a valuable patient-oriented support tool in sleep medicine therapy that can enhance subsequent face-to-face consultations with a sleep specialist. However, some substantial flaws regarding second line HGNS therapy are most likely due to recent advances in HGNS therapy and the consequent limited information available in LLM training data.
期刊介绍：
Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.
Specific topics covered in the journal include:
The functions of sleep in humans and other animals
Physiological and neurophysiological changes with sleep
The genetics of sleep and sleep differences
The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness
Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness
Sleep changes with development and with age
Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause)
The science and nature of dreams
Sleep disorders
Impact of sleep and sleep disorders on health, daytime function and quality of life
Sleep problems secondary to clinical disorders
Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health)
The microbiome and sleep
Chronotherapy
Impact of circadian rhythms on sleep, physiology, cognition and health
Mechanisms controlling circadian rhythms, centrally and peripherally
Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health
Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption
Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms
Epigenetic markers of sleep or circadian disruption.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
